Related Experiment Videos

Human plasma alpha1-proteinase inhibitor: temporary inhibition and multiple molecular forms of the complex with

K Oda, M Laskowski, L F Kress

Biochemical and Biophysical Research Communications

|June 20, 1977

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study.

ESMO open·2025

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial.

ESMO open·2021

ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

QT Interval Shortening With Isavuconazole: In Vitro and In Vivo Effects on Cardiac Repolarization.

Clinical pharmacology and therapeutics·2017

Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer.

Cancer chemotherapy and pharmacology·2013

See all related articles